While no single direct mechanism has been definitively established, fatigue likely results from multiple factors including substantial caloric restriction, gastrointestinal side effects, dehydration, and metabolic adaptation during weight loss
Costly GLP-1 drugs are rarely covered for weight loss by Marketplace plans
The American Thyroid Association, the Endocrine Society, and the FDA have not identified autoimmune thyroid disease as a reason to avoid these medications
Maximization of weight reduction A structured, comprehensive nutrition and lifestyle program could help augment the weight reduction efficacy of GLP-1s, although findings have been mixed
The warning reads: The following adverse reactions have been reported during post-approval use of semaglutide, the active ingredient of OZEMPIC